Arrhythmias & electrophysiologyGuideline or statement
ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing
- Appropriate use criteria document
Recommendations
As issued by the authors
- Appropriate (median 7 to 9)
Scenarios with clinical trial evidence and/or clinical experience supporting device implantation
- May Be Appropriate (median 4 to 6)
Scenarios with limited clinical trial evidence, or where implantation seemed reasonable for extenuating or practical reasons
- Rarely Appropriate (median 1 to 3)
Scenarios with data showing harm, or no data, where medical judgment deemed device therapy ill-advised; e.g. reduced life expectancy from noncardiac conditions or severe cognitive dysfunction lowers ratings
Original publication
ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing. J Am Coll Cardiol. Published 13 January 2025. doi:10.1016/j.jacc.2024.11.023
Summarised from the published abstract; every number is checked against it